Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 136

    Merck will now be called Procter & Gamble Health

    Merck will now be called Procter & Gamble Health

    Farhat Nasim7 May 2019 10:05 AM IST
    Merck has received approval from the Registrar of Companies, Mumbai, Maharashtra, for change of name from Merck Ltd to Procter & Gamble Health Ltd...
    Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

    Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis

    Medical Dialogues Bureau7 May 2019 9:45 AM IST
    Pfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under...
    Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

    Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

    Medical Dialogues Bureau7 May 2019 9:25 AM IST
    The drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...
    Medlife acquires medicine delivery startup Myra Medicines

    Medlife acquires medicine delivery startup Myra Medicines

    Garima7 May 2019 9:00 AM IST
    Myra's acquisition will enable the company to strengthen its pharma business and accrue profits, Medlife said in a statement.New Delhi: Health-tech...
    Dr Reddys launches generic version of AndroGel in US market

    Dr Reddys launches generic version of AndroGel in US market

    Farhat Nasim6 May 2019 10:15 AM IST
    The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved...
    Non-compliance of norms: USFDA recommends action against Strides Pharma Puducherry facility

    Non-compliance of norms: USFDA recommends action against Strides Pharma Puducherry facility

    Farhat Nasim6 May 2019 10:05 AM IST
    Strides Pharma has received a communication from the US Food and Drug Administration (USFDA) on May 4, 2019, classifying the facility as OAI based on...
    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Farhat Nasim6 May 2019 10:00 AM IST
    Lupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to "failed impurities/degradation...
    Aster DM Healthcare to infuse Rs 750 crore to add 1500 beds in four new hospitals

    Aster DM Healthcare to infuse Rs 750 crore to add 1500 beds in four new hospitals

    Garima6 May 2019 9:45 AM IST
    "We will be investing around Rs 750 crore to add 1,500 beds in the four hospitals we will be opening in India by the end of March 2022," Aster DM...
    Patent Infringement: Vectura wins case against GSK; awarded $89.7 million in damages

    Patent Infringement: Vectura wins case against GSK; awarded $89.7 million in damages

    Farhat Nasim6 May 2019 9:30 AM IST
    Vectura started legal proceedings against GSK in July 2016 after a patent license agreement between the two companies expired and GSK declined to...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 9:15 AM IST
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting

    Farhat Nasim5 May 2019 10:00 AM IST
    Emgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
    Abbott receives WHO prequalification approval for breakthrough HIV point-of-care test

    Abbott receives WHO prequalification approval for breakthrough HIV point-of-care test

    Farhat Nasim5 May 2019 9:45 AM IST
    New Delhi: Abbott recently announced that m-PIMA HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health...
    PrevNext

    Popular Stories

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok